Veeva Systems Inc. (NYSE:VEEV – Get Free Report) insider Thomas Schwenger sold 36,000 shares of the stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $250.23, for a total value of $9,008,280.00. Following the completion of the sale, the insider owned 19,449 shares in the company, valued at $4,866,723.27. This trade represents a 64.92% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Veeva Systems Stock Performance
Veeva Systems stock traded down $5.35 during midday trading on Monday, hitting $238.40. 1,007,368 shares of the company’s stock were exchanged, compared to its average volume of 2,498,673. Veeva Systems Inc. has a 52-week low of $148.05 and a 52-week high of $310.50. The stock has a 50-day moving average price of $189.96 and a two-hundred day moving average price of $180.54. The company has a market cap of $38.73 billion, a P/E ratio of 42.50, a PEG ratio of 1.05 and a beta of 0.92.
Veeva Systems (NYSE:VEEV – Get Free Report) last released its quarterly earnings results on Wednesday, June 3rd. The technology company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. The firm had revenue of $882.95 million for the quarter, compared to analysts’ expectations of $857.73 million. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The company’s revenue was up 16.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.97 EPS. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. As a group, sell-side analysts expect that Veeva Systems Inc. will post 6.65 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on VEEV
Institutional Investors Weigh In On Veeva Systems
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Empire Life Investments Inc. grew its holdings in Veeva Systems by 21.1% in the 4th quarter. Empire Life Investments Inc. now owns 37,054 shares of the technology company’s stock worth $8,272,000 after acquiring an additional 6,453 shares during the last quarter. Czech National Bank bought a new position in shares of Veeva Systems during the second quarter valued at about $7,584,000. Farther Finance Advisors LLC boosted its holdings in shares of Veeva Systems by 217.2% during the fourth quarter. Farther Finance Advisors LLC now owns 10,470 shares of the technology company’s stock worth $2,337,000 after purchasing an additional 7,169 shares during the period. Pictet Asset Management Holding SA boosted its holdings in shares of Veeva Systems by 14.2% during the fourth quarter. Pictet Asset Management Holding SA now owns 1,110,075 shares of the technology company’s stock worth $247,817,000 after purchasing an additional 137,965 shares during the period. Finally, BNP Paribas grew its stake in shares of Veeva Systems by 89.3% in the fourth quarter. BNP Paribas now owns 19,239 shares of the technology company’s stock worth $4,308,000 after purchasing an additional 9,077 shares during the last quarter. 88.20% of the stock is currently owned by institutional investors.
Veeva Systems Company Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Articles
- Five stocks we like better than Veeva Systems
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
